|Over a week ago|
Danaher director sells 18.3K shares of common stock » 17:1405/1905/19/20
In a regulatory filing,…
In a regulatory filing, Danaher disclosed that its EVP Daniel Comas sold 18.3K shares of common stock on May 18th. The total transaction size was $3.0M.
Third Point adds Disney, exits Campbell Soup in Q1 » 16:5005/1505/15/20
AMZN, AMTD, FIVE, FOXA, BSX, CPB, SERV, TEL, ROP, CHTR, DIS, CNC, RACE, BAX, RTN, BURL, CRM, IQV, DHR, FIS
Third Point disclosed in…
Third Point disclosed in an SEC filing its holdings as of March 31, 2020. The fund's seven new buys during the first quarter included, by size of position, Disney (DIS), Charter Communications (CHTR), Roper Technologies (ROP), TE Connectivity (TEL), and ServiceMaster Global (SERV). Third Point exited 13 positions during the quarter, including by size of previous position Campbell Soup (CPB), Boston Scientific (BSX), Fox Corp. Class A (FOXA), Five Below (FIVE), and TD Ameritrade (AMTD). The fund increased its stake in five holdings, including Amazon (AMZN), Centene (CNC), and Ferrari (RACE). Third Point reduced its stake in 12 holdings, including by size of previous position Baxter (BAX), Raytheon Technologies (RTN), Burlington Stores (BURL), Salesforce (CRM), and Iqvia (IQV). The fund's top holdings as of March 31, in order of size, were Baxter, Danaher (DHR), Amazon, Centene, and Fidelity National Information Services (FIS).
Beckman Coulter awarded expanded partnership with BARDA » 12:3705/1505/15/20
Beckman Coulter, a unit…
Beckman Coulter, a unit of Danaher, announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to Beckman Coulter, in collaboration with Dascena, Inc., for additional advanced research and development toward optimization of a machine-learning based sepsis diagnostic and prediction algorithm to include assessing its use with coronavirus patients. The sepsis diagnostic and prediction algorithm builds on Beckman Coulter's existing Early Sepsis Indicator, which received FDA 510(k) clearance in April 2019, combining the monocyte distribution width novel laboratory test parameter values with Dascena's electronic health record data based machine-learning algorithm to help accurately predict and detect those with sepsis This COVID-19 specific study is part of BARDA's Rapidly Deployable Capabilities program to identify and pilot near-term innovative solutions for COVID-19, leveraging the development of Beckman Coulter's digital sepsis prediction algorithm under BARDA's Division of Research Innovation and Venture's Solving Sepsis Program.
Danaher directors sell 37K shares and 34K shares of common stock » 17:3305/1205/12/20
In regulatory filings,…
In regulatory filings, Danaher disclosed that its Chief Accounting Officer Robert Lutz sold 34K shares of common stock and SVP of HR Angela Lalor sold 37K shares of common stock on May 8th.
Danaher General Counsel sells 2.9K shares of common stock » 17:2905/1205/12/20
In a regulatory filing,…
In a regulatory filing, Danaher disclosed that its General Counsel Brian Ellis sold 2,870 shares of common stock on May 8th. The total transaction size was $469K.
Danaher price target raised to $173 from $159 at RBC Capital » 06:4905/1105/11/20
RBC Capital analyst Deane…
RBC Capital analyst Deane Dray raised the firm's price target on Danaher to $173 from $159 and keeps an Outperform rating on the shares after its "high-quality" earnings beat and in-line Q2 guidance. The analyst notes that while the CEO transition announcement was unexpected, the succession should be "seamless". Dray adds that Danaher's balance sheet suggests that the company is preparing to "play offense on M&A", further stating that the COVID-testing upside also position Danaher well.
Danaher 9.509M share Secondary priced at $163.00 » 06:1505/0805/08/20
The deal size was…
The deal size was increased to $1.50B in common stock from $1.25B. Goldman Sachs, JPMorgan, Citi and Evercore ISI acted as joint book running managers for the offering.
Danaher to offer $1.25B in common stock, $1.25B in convertible preferred stock » 08:5705/0705/07/20
Danaher announced that it…
Danaher announced that it has commenced concurrent offerings of $1.25 billion of shares of common stock and $1.25 billion of shares of Series B Mandatory Convertible Preferred Stock Goldman Sachs & Co. LLC, J.P. Morgan, Citigroup and Evercore, are acting as representatives of the underwriters and joint book-running managers for the offerings.
Notable companies reporting before tomorrow's open » 20:2505/0605/06/20
BMY, DHR, RTX, FIS, BUD, BDX, HLT, ABC, VIAC, ELAN, CFX, JBLU, COMM, PENN, VG
Notable companies reporting before tomorrow's open, with earnings consensus, include Bristol-Myers Squibb (BMY), consensus $1.49... Danaher (DHR), consensus $1.01... Raytheon Technologies (RTX), consensus $1.22... FIS (FIS), consensus $1.28... AB InBev (BUD), consensus (7c)... Becton Dickinson (BDX), consensus $2.36... Hilton (HLT), consensus 57c... AmerisourceBergen (ABC), consensus $2.27... ViacomCBS (VIAC), consensus 94c... Elanco Animal Health (ELAN), consensus 23c... Colfax (CFX), consensus 37c... JetBlue (JBLU), consensus (37c)... CommScope (COMM), consensus 7c... Penn National (PENN), consensus 18c... Vonage (VG), consensus 1c.
Danaher: Rainer Blair to succeed Thomas Joyce as CEO in September » 16:1305/0605/06/20
Danaher announced that…
Danaher announced that Executive Vice President, Rainer Blair, will succeed Thomas Joyce Jr. as President and CEO and as a member of the company's Board of Directors, upon Joyce's retirement from these positions on September 1. Joyce will continue as a senior advisor at Danaher through February 28, 2021.